ABEO
Abeona Therapeutics Inc.$2.58+0.16 (+6.73%)Prev Close$2.42·MCap$138.3M·P/E2.37·Vol1.65M·Yield616.68%
▲
Buys (12M)
1
$34.3K
▼
Sells (12M)
34
$4.54M
◆
Net Activity
Net Seller
$4.51M
●
Active Insiders
10
last 12 mo
Over the past 12 months, insider activity at Abeona Therapeutics Inc. (ABEO) has been dominated by selling, with 1 insider purchase totaling $34.3K and 34 insider sales totaling $4.54M. The most recent insider transaction was by Charles Faith L. (director), who purchased $34.3K worth of shares on Nov 16, 2026. Abeona Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $138.3M.
ABEO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Charles Faith L. | director | Buy | 15,000 | $2.29 | $34.3K | 191,407 |
| Sep 29, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 19,608 | $5.16 | $101.1K | 1,286,500 |
| Sep 29, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 4,902 | $5.16 | $25.3K | 285,721 |
| Sep 29, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 9,191 | $5.16 | $47.4K | 482,888 |
| Sep 29, 2026 | O'Malley Brendan M. | officer: SVP, Chief Legal Officer | Sell | 6,727 | $5.16 | $34.7K | 421,226 |
| Sep 1, 2026 | Alvino Mark | director | Sell | 15,000 | $5.86 | $88.0K | 62,065 |
| Jul 22, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 1,478 | $6.53 | $9.7K | 492,079 |
| Jul 9, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 67,971 | $6.96 | $473.3K | 1,306,108 |
| Jul 9, 2026 | O'Malley Brendan M. | officer: SVP, Chief Legal Officer | Sell | 12,050 | $6.96 | $83.9K | 427,953 |
| Jul 9, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 12,606 | $6.96 | $87.8K | 290,623 |
| Jul 9, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 24,880 | $6.96 | $173.3K | 493,557 |
| Jul 2, 2026 | Alland Leila | director | Sell | 11,000 | $5.92 | $65.1K | 162,614 |
| Jun 15, 2026 | Silverstein Christine Berni | director | Sell | 18,160 | $5.71 | $103.7K | 119,562 |
| Jun 9, 2026 | O'Malley Brendan M. | officer: SVP, Chief Legal Officer | Sell | 11,131 | $5.36 | $59.6K | 446,308 |
| Jun 9, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 9,620 | $5.36 | $51.5K | 308,901 |
| Jun 9, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 49,338 | $5.38 | $265.2K | 557,504 |
| Jun 9, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 56,344 | $5.36 | $301.9K | 1,405,995 |
| May 22, 2026 | Alvino Mark | director | Sell | 6,500 | $5.46 | $35.5K | 77,565 |
| May 15, 2026 | Crombez Eric | director | Sell | 26,143 | $5.53 | $144.6K | 37,313-41% |
| May 11, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 5,548 | $5.96 | $33.1K | 313,071 |
| Mar 31, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 29,985 | $4.38 | $131.5K | 1,430,423 |
| Mar 16, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 785 | $4.76 | $3.7K | 567,775 |
| Feb 4, 2026 | Silverstein Christine Berni | director | Sell | 20,070 | $5.09 | $102.2K | 137,722 |
| Feb 2, 2026 | Alland Leila | Director | Sell | 36,130 | $5.09 | $183.9K | 173,614 |
| Feb 2, 2026 | Alvino Mark | Director | Sell | 4,000 | $5.09 | $20.4K | 84,065 |
| Feb 2, 2026 | Crombez Eric | Director | Sell | 32,568 | $5.09 | $165.8K | 63,456-34% |
| Feb 2, 2026 | Wuchterl Donald A. | Director | Sell | 29,628 | $5.09 | $150.8K | 167,935 |
| Feb 2, 2026 | Silverstein Christine Berni | Director | Sell | 20,070 | $5.09 | $102.2K | 0 |
| Jan 26, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 12,610 | $5.29 | $66.7K | 318,619 |
| Jan 22, 2026 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 27,156 | $5.33 | $144.8K | 451,134 |
| Jan 22, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 139,664 | $5.33 | $744.5K | 1,460,408 |
| Jan 22, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 37,332 | $5.33 | $199.0K | 568,560 |
| Jan 21, 2026 | Alvino Mark | Director | Sell | 27,000 | $5.23 | $141.1K | 48,752-36% |
| Jan 20, 2026 | Vasanthavada Madhav | Chief Commercial Officer | Sell | 12,610 | $5.29 | $66.7K | 0 |
| Dec 29, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 25,000 | $5.31 | $132.7K | 0 |
| Nov 13, 2025 | Alvino Mark | Director | Sell | 15,000 | $4.74 | $71.2K | 0 |
| Oct 16, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 249 | $5.49 | $1.4K | 0 |
| Sep 29, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 9,366 | $5.39 | $50.5K | 0 |
| Sep 29, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 44,274 | $5.31 | $234.9K | 0 |
| Sep 29, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 9,035 | $5.39 | $48.7K | 0 |
| Sep 22, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 688 | $5.43 | $3.7K | 0 |
| Aug 15, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 15,000 | $7.36 | $110.4K | 0 |
| Aug 14, 2025 | Crombez Eric | Director | Sell | 4,718 | $6.93 | $32.7K | 0 |
| Jul 22, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 1,502 | $6.64 | $10.0K | 0 |
| Jul 9, 2025 | Charles Faith L. | Director | Sell | 10,738 | $5.86 | $62.9K | 0 |
| Jul 9, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 17,428 | $5.86 | $102.1K | 0 |
| Jul 9, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 69,420 | $5.86 | $406.5K | 0 |
| Jul 9, 2025 | Silverstein Christine Berni | Director | Sell | 13,093 | $5.86 | $76.7K | 0 |
| Jul 9, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 25,411 | $5.86 | $148.8K | 0 |
| Jul 8, 2025 | Wuchterl Donald A. | Director | Sell | 5,176 | $5.82 | $30.1K | 0 |
Showing 1–50 of 125
1 / 3
ABEO Insider Buying Activity
The following table shows recent insider purchases of Abeona Therapeutics Inc. (ABEO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Charles Faith L. | director | Buy | 15,000 | $2.29 | $34.3K | 191,407 |
ABEO Insider Selling Activity
The following table shows recent insider sales of Abeona Therapeutics Inc. (ABEO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 19,608 | $5.16 | $101.1K | 1,286,500 |
| Sep 29, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 4,902 | $5.16 | $25.3K | 285,721 |
| Sep 29, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 9,191 | $5.16 | $47.4K | 482,888 |
| Sep 29, 2026 | O'Malley Brendan M. | officer: SVP, Chief Legal Officer | Sell | 6,727 | $5.16 | $34.7K | 421,226 |
| Sep 1, 2026 | Alvino Mark | director | Sell | 15,000 | $5.86 | $88.0K | 62,065 |
| Jul 22, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 1,478 | $6.53 | $9.7K | 492,079 |
| Jul 9, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 67,971 | $6.96 | $473.3K | 1,306,108 |
| Jul 9, 2026 | O'Malley Brendan M. | officer: SVP, Chief Legal Officer | Sell | 12,050 | $6.96 | $83.9K | 427,953 |
| Jul 9, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 12,606 | $6.96 | $87.8K | 290,623 |
| Jul 9, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 24,880 | $6.96 | $173.3K | 493,557 |
| Jul 2, 2026 | Alland Leila | director | Sell | 11,000 | $5.92 | $65.1K | 162,614 |
| Jun 15, 2026 | Silverstein Christine Berni | director | Sell | 18,160 | $5.71 | $103.7K | 119,562 |
| Jun 9, 2026 | O'Malley Brendan M. | officer: SVP, Chief Legal Officer | Sell | 11,131 | $5.36 | $59.6K | 446,308 |
| Jun 9, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 9,620 | $5.36 | $51.5K | 308,901 |
| Jun 9, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 49,338 | $5.38 | $265.2K | 557,504 |
| Jun 9, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 56,344 | $5.36 | $301.9K | 1,405,995 |
| May 22, 2026 | Alvino Mark | director | Sell | 6,500 | $5.46 | $35.5K | 77,565 |
| May 15, 2026 | Crombez Eric | director | Sell | 26,143 | $5.53 | $144.6K | 37,313-41% |
| May 11, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 5,548 | $5.96 | $33.1K | 313,071 |
| Mar 31, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 29,985 | $4.38 | $131.5K | 1,430,423 |
| Mar 16, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 785 | $4.76 | $3.7K | 567,775 |
| Feb 4, 2026 | Silverstein Christine Berni | director | Sell | 20,070 | $5.09 | $102.2K | 137,722 |
| Feb 2, 2026 | Alland Leila | Director | Sell | 36,130 | $5.09 | $183.9K | 173,614 |
| Feb 2, 2026 | Alvino Mark | Director | Sell | 4,000 | $5.09 | $20.4K | 84,065 |
| Feb 2, 2026 | Crombez Eric | Director | Sell | 32,568 | $5.09 | $165.8K | 63,456-34% |
| Feb 2, 2026 | Wuchterl Donald A. | Director | Sell | 29,628 | $5.09 | $150.8K | 167,935 |
| Feb 2, 2026 | Silverstein Christine Berni | Director | Sell | 20,070 | $5.09 | $102.2K | 0 |
| Jan 26, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 12,610 | $5.29 | $66.7K | 318,619 |
| Jan 22, 2026 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 27,156 | $5.33 | $144.8K | 451,134 |
| Jan 22, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 139,664 | $5.33 | $744.5K | 1,460,408 |
| Jan 22, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 37,332 | $5.33 | $199.0K | 568,560 |
| Jan 21, 2026 | Alvino Mark | Director | Sell | 27,000 | $5.23 | $141.1K | 48,752-36% |
| Jan 20, 2026 | Vasanthavada Madhav | Chief Commercial Officer | Sell | 12,610 | $5.29 | $66.7K | 0 |
| Dec 29, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 25,000 | $5.31 | $132.7K | 0 |
| Nov 13, 2025 | Alvino Mark | Director | Sell | 15,000 | $4.74 | $71.2K | 0 |
| Oct 16, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 249 | $5.49 | $1.4K | 0 |
| Sep 29, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 9,366 | $5.39 | $50.5K | 0 |
| Sep 29, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 44,274 | $5.31 | $234.9K | 0 |
| Sep 29, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 9,035 | $5.39 | $48.7K | 0 |
| Sep 22, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 688 | $5.43 | $3.7K | 0 |
| Aug 15, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 15,000 | $7.36 | $110.4K | 0 |
| Aug 14, 2025 | Crombez Eric | Director | Sell | 4,718 | $6.93 | $32.7K | 0 |
| Jul 22, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 1,502 | $6.64 | $10.0K | 0 |
| Jul 9, 2025 | Charles Faith L. | Director | Sell | 10,738 | $5.86 | $62.9K | 0 |
| Jul 9, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 17,428 | $5.86 | $102.1K | 0 |
| Jul 9, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 69,420 | $5.86 | $406.5K | 0 |
| Jul 9, 2025 | Silverstein Christine Berni | Director | Sell | 13,093 | $5.86 | $76.7K | 0 |
| Jul 9, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 25,411 | $5.86 | $148.8K | 0 |
| Jul 8, 2025 | Wuchterl Donald A. | Director | Sell | 5,176 | $5.82 | $30.1K | 0 |
ABEO Insiders
Seshadri Vishwas
director, officer: Chief Executive Officer
Bought $201.2KSold $3.35M
24 tradesLast: Sep 29, 2026
Vazzano Joseph Walter
officer: Chief Financial Officer
Bought $39.1KSold $1.29M
22 tradesLast: Sep 29, 2026
Similar Stocks to ABEO
VRTX
Vertex Pharmaceuticals Incorporated
$535.71-0.54%
$138.69B
REGN
Regeneron Pharmaceuticals, Inc.
$951.76-0.39%
$99.23B
MRNA
Moderna, Inc.
$215.63-3.39%
$93.61B
RVMD
Revolution Medicines, Inc.
$166.91-3.13%
$39.08B
INSM
Insmed Incorporated
$123.03+1.55%
$26.58B
UTHR
United Therapeutics Corporation
$582.48-1.47%
$25.18B
INCY
Incyte Corporation
$120.36-0.50%
$24.66B
ALNY
Alnylam Pharmaceuticals, Inc.
$159.72-3.23%
$21.41B